[Seroprevalence to SARS-CoV-2 among the population of the Belgorod Region amid the COVID-19 epidemic]
GHDx Entry last modified on: Jun 17, 2021
Blood tests
Dataset Records for Blood tests
Displaying 1 - 50 of 1253
Netherlands - Coronavirus antibodies in an average of 18.6% of the donors
Antistoffen coronavirus bij gemiddeld 18,6% van de donors
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Prevalence of anti-SARS-CoV-2 antibodies among blood donors in Northern Cape, KwaZulu-Natal, Eastern Cape, and Free State provinces of South Africa in January 2021. Preprint
GHDx Entry last modified on: Jun 17, 2021
COVID Symptoms, Seroprevalence, and Mortality During the First Wave of SARS-CoV-2 in Canada. Preprint.
GHDx Entry last modified on: Nov 5, 2021
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey
Survey:
Epi surveillance
United States - COVID-19 Diagnostic Laboratory Testing (PCR Testing) Time Series
Epi surveillance:
Health facility - Subnationally representative
SARS-CoV-2 infection and transmission in school settings during the second wave in Berlin, Germany: a cross-sectional study. Preprint
GHDx Entry last modified on: Jun 17, 2021
High Seroprevalence of SARS-CoV-2 Eight Months After Introduction in Nairobi, Kenya. Preprint
GHDx Entry last modified on: Nov 5, 2021
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Nepal National Sero-Prevalence Survey for COVID-19 2020 Round 1
ENHANCED SURVEILLANCE ON SERO-PREVALENCE OF SARS-COV-2 IN GENERAL POPULATION
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
India - Haryana Covid-19 Sero Survey Round 2, October 2020
Sero-prevalence of Anti-SARS-CoV-2 IgG antibodies in Haryana, India: A Population based Cross-Sectional Study (2nd Round)
Survey:
Cross-sectional - Epi surveillance - Urban-rural representative
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: Jun 29, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
SARS-CoV-2 infections in kindergartens and associated households at the start of the second wave in Berlin, Germany – a cross sectional study. Preprint
GHDx Entry last modified on: Jun 17, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Kolkata: One in Four People Have Covid Antibodies
GHDx Entry last modified on: Jul 27, 2021
C''garh: 5.5 pc people have COVID-19 antibodies, says sero survey
Survey:
Cross-sectional - Epi surveillance - Individual
Canada COVID-19 Seroprevalence in Ontario: September 3 to October 30, 2020
GHDx Entry last modified on: Oct 19, 2021
India - Haryana Covid -19 Sero Survey Round 1, August 2020
Sero-prevalence of anti-SARS-CoV-2 IgG antibodies in Haryana, India: a Population-Based Cross Sectional Study
Survey:
Epi surveillance
Serum-epidemiological Survey of SARS-CoV-2, City of Quelimane (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Quelimane (InCOVID 2020) - Resultados Preliminares -
Canada COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
COVID-19 Seroprevalence in Ontario: August 1 to August 31, 2020
[Preliminary results of the National Health and Nutrition Survey COVID-19]
Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19
Survey:
Cross-sectional - Epi surveillance - Household - Individual - Nationally representative
United States - Washington Hospitalized or Ambulatory Adults with Respiratory Viral Infections 2020
HAARVI
Survey:
Health facility - Longitudinal - Outpatient
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares -
Canada COVID-19 Seroprevalence in Ontario: July 4 to July 31, 2020
GHDx Entry last modified on: Oct 19, 2021
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Loreto, Peru. Preprint
GHDx Entry last modified on: Jun 18, 2021
Serum-epidemiological Survey of SARS-CoV-2, City of Pemba (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Pemba (InCOVID 2020) - Resultados Preliminares -
Israel - Press Releases Results of the National Serological Survey for Novel Coronavirus
GHDx Entry last modified on: Jul 2, 2021
Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease Progression
GHDx Entry last modified on: Jun 18, 2021
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 seroprevalence in Germany - a population based sequential study in five regions. Preprint
GHDx Entry last modified on: Jun 17, 2021
Seroprevalence of anti-SARS-CoV-2 IgG at the epidemic peak in French Guiana. Preprint
GHDx Entry last modified on: Jun 17, 2021
Assam’s First Sero-survey Gets Underway, Here’s Everything You Need To Know About It
GHDx Entry last modified on: Feb 23, 2021
Montenegro Institute of Public Health COVID-19 Dashboard June 2020
GHDx Entry last modified on: Oct 19, 2021
Variation in SARS-CoV-2 seroprevalence in school-children across districts, schools and classes. Preprint
GHDx Entry last modified on: Jun 17, 2021
Prevalence of SARS-CoV-2 in Karnataka, India
GHDx Entry last modified on: Jun 17, 2021
[Minsa publishes technical data of the study that reveals that 25.3% of Lima and Callao acquired COVID-19]
Minsa divulga ficha técnica del estudio que revela que el 25.3% de Lima y Callao adquirió el COVID-19
Survey:
Epi surveillance
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults. Preprint
GHDx Entry last modified on: Sep 17, 2021
One in Three Exposed to Covid Virus, Reveals Second Chennai Sero Survey
GHDx Entry last modified on: Jul 27, 2021
Presence of antibodies against SARS-CoV-2 in the district area Rinkeby-Kista, Stockholm, 22–24 June 2020
Förekomsten av antikroppar mot SARS-CoV-2 i stadsdelsområdet Rinkeby-Kista, Stockholm, 22–24 juni 2020
Survey:
Community - Cross-sectional - Exam - Urban only
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 antibody prevalence and symptoms in a local Austrian population. Preprint
GHDx Entry last modified on: Jun 17, 2021
Ireland Study to Investigate COVID-19 Infection in People Living in Ireland (SCOPI) 2020
Survey:
Epi surveillance
Subscribe